GSK’s Shingrix received chinese approval for shingles vaccine
Posted on24 May 2019
Comments0
GaxoSmithKline (GSK) has secured approval from China’s National Medical Products Administration (NMPA) for Shingrix vaccine to prevent shingles (herpes zoster) in adults... Read More
Overview of China Pharmaceutical Market
The China pharmaceutical market is the second largest in the world after the United States, and in 2014 was worth 109.3 billion... Read More